Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A new method for the early diagnosis of pulmonary hypertension, the main cause of death in patients with scleroderma

14.11.2007
Researchers at the University of Granada (UGR) from the Systemic Autoimmune Diseases Unit and the Cardiology Service of the Hospital Clínico San Cecilio in Granada have developed an innovative system which will help doctors make the earliest diagnosis of pulmonary hypertension possible, which is the main cause of death for patients suffering from scleroderma, a rare disease which affects approximately 1,200 out of every million people.

Until now, the only method to identify pulmonary hypertension was to perform a cardiac catheterization, an invasive technique consisting of the insertion of a hollow and flexible tube (a catheter) through the jugular vein directly into the right side of the heart. This technique is not advisable for all patients because of its complexity and risk.

The new technique was developed by doctor Lourdes López Pérez, and directed by lecturers Norberto Ortego Centeno and José Luis Callejas Rubio, from the Systemic Autoimmune Diseases Unit of the Medicine Department, at the University of Granada.

They worked in collaboration with the cardiologists Eduardo Moreno Escobar and Pilar Martín de la Fuente. The great advantage of this system, which is based on the ultrasound technique, is that it allows specialists to measure the pulmonary artery systolic pressure so that pulmonary hypertension can be diagnosed earlier.

A destructive disease
Scleroderma is a systemic autoimmune disease, that is to say, it affects various organs of the body, and it is due to an alteration of the immune system. This disease is specially characterised by colour changing of the hands when exposed to cold, which is known as Raynaud’s phenomenon, and causes skin swelling from fingers to wrists. Scleroderma is also characterised by damage in the skin of hands, neck and face. This damage resembles little spider veins known as telangiectasias. In addition to this, other organs such as the oesophagus, the kidneys or the lungs may be affected.

Lung damage is one of the most significant and serious symptoms, being the leading cause of death among patients suffering from scleroderma. The research team from the University of Granada maintained detailed medical records of each of the 41 patients included in order to accomplish this study. They also included data from both blood and respitatory tests. An echocardiogram was performed on all patients while they were resting and after physical effort on a special bicycle, called a bicycle ergometer.

From the results of this study, it has been concluded that there is a group of patients who present a serious pathological increase of pulmonary artery systolic pressure when exercising. Therefore, these findings are very early evidence of scleroderma. Thanks to this early diagnosis a suitable treatment can be started to modify the scleroderma cycle, thus improving patient’s prognosis significantly.

Early diagnosis
Given that pulmonary hypertension is a very serious complication of scleroderma, Lourdes López stresses the importance of diagnosing it as soon as possible in order to foresee the appearance of symptoms ascribed to it, such as breathing difficulty while partaking in physical activity or dyspnea.

She also states that using the bicycle ergometer to measure pulmonary artery systolic pressure of the patient after physical activity and performing an echocardiogram are very reliable methods, since they may help to identify scleroderma earlier.

The results of this new research confirms the importance of performing an echocardiogram on patients suffering from scleroderma, since this fatal complication may be indentified before it becomes irreversible. Some of the results of this pioneering research have already been published in prestigious international journals, such as the European Journal of Echocardiography, the official publication of the European Association of Echocardiography (EAE), and Chest, a publication of the American College of Chest Physicians (ACCP).

Antonio Marín Ruiz | alfa
Further information:
http://prensa.ugr.es/prensa/research/index.php

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>